Skip to main content
. 2019 Sep 16;2019:3717683. doi: 10.1155/2019/3717683

Table 3.

Differentially expressed miRNAs among the MTC, benign nodule, and the healthy control groups by qRT-PCRa.

miRNA MTC (n = 15) Benign nodule (n = 15) Healthy control (n = 15) P valueb P valuec P valued
miR-222-3p 0.731 ± 0.035 0.376 ± 0.066 0.253 ± 0.028 <0.001 <0.001 0.098
miR-17-5p 2.719 ± 0.184 1.669 ± 0.322 1.079 ± 0.163 <0.01 <0.001 0.113
miR-451a 0.803 ± 0.028 0.836 ± 0.043 0.629 ± 0.059 0.533 <0.05 <0.01

MTC: medullary thyroid carcinoma. aThe relative contents of miRNAs are normalized to let-7d/g/i and presented as mean ± SEM. bDifference between the MTC group and the benign nodule group. cDifference between the MTC group and the healthy control group. dDifference between the benign nodule group and the healthy control group.